Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

Autor: Mittendorf, E.A., Clifton, G.T., Holmes, J.P., Schneble, E., van Echo, D., Ponniah, S., Peoples, G.E. *
Zdroj: In Annals of Oncology September 2014 25(9):1735-1742
Databáze: ScienceDirect